November 2015

Byunghun won the Silver Award in the highly competitive “The 11th Samsung Electro-Mechanics Best Paper Awards”. The title of his paper was “A Multi-Cycle Q-Modulation Technique for Wirelessly-Powered Biomedical Implants.” You may find more information here.

October 2015

Yaoyao, Zheyuan, and Abdollah won the Best Live Demo Award at the 2015 IEEE Biomedical Circuits and Systems Conference. Their demo was titled: “Live Demonstration: A Smart Homecage System with Behavior Analysis and Closed-Loop Optogenetic Stimulation Capabilities”. You may find more information here.

August 2015

GT-Bionics lab will participate in the 2015 IEEE Biomedical Circuits and Systems Conference (BioCAS'15) with 6 papers. BioCAS serves as a premier international forum for presenting the interdisciplinary research and development at the crossroads of medicine, life sciences, physical sciences and engineering that will shape tomorrow's medical devices and healthcare systems.

July 2015

Congratulations to Dr. Sarah Ostadabbas for accepting a faculty position at Northeastern University. We at the GT Bionics lab look forward to you making us all proud. We'll miss you!

March 2015

Dr. Ghovanloo was named an IEEE Circuits and Systems Society Distinguished Lecturer for 2015-2016 term. The topics on which he will lecture are "Implantable and Wearable Microelectronic Devices to Improve Quality of Life for People with Disabilities" and "Efficient Power and Wideband Data Transmission in Near Field."

November 2014

Tongue Drive featured in US NEWS and World Report: Wearable Tech for People With Disabilities.

Pharmaceutical Compliance
Monitoring System

Patients forget to take their medicine, they may think side effects outweigh benefits, they may not believe the diagnosis, they may not understand the directions correctly, they may not know enough about the side-effects, they may use too much, or they may view the medicine as too costly. For whatever reason, even the best medications cannot cure diseases if the patients do not take them in the right doses at the right time. The topic of “pharmaceutical compliance” has become a key issue due to increasing difficulties in achieving point-of-differentiation and health economic objectives justifying premium pricing and reimbursement. We are working on a novel drug compliance monitoring device suitable for clinical and pharmaceutical trials. It can also be an integrated part of the marketed drug concepts.